Hipra Scientific, S.l.u

This study tested a new booster vaccine for COVID-19 in 913 adults who had already received initial vaccines and at least one booster. The goal was to see if the new booster is safe and triggers a strong immune response against newer virus variants. Participants received either t…

This study tested a new booster vaccine called PHH-1V in 887 adults who had already received two doses of the Pfizer COVID-19 vaccine. The goal was to see if PHH-1V could safely boost immunity as well as or better than another Pfizer dose. The trial also looked at giving a fourth…

This study tested an extra dose of a new COVID-19 vaccine (PHH-1V) in 241 adults with weakened immune systems, such as those with HIV, kidney disease, or autoimmune disorders. The goal was to see if the booster could improve their protection against the virus and its variants. Re…

This study tested whether BIMERVAX, a COVID-19 booster shot, is safe and works well in teenagers aged 12 to 17. About 242 teens who had already received a different COVID vaccine got one dose of BIMERVAX. Researchers measured their immune response and tracked any side effects for…